Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

E-Therapeutics PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Apr 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - E-THERAPEUTICS PLC (ETX-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Apr 2015 Thomson Reuters Stock Report 9 $25.00

E-THERAPEUTICS - NETWORK PHARMACOLOGY COMING OF AGE

e-Therapeutics is pioneering the concept of network pharmacology, a novel approach that could revolutionise drug discovery. T...

27 Apr 2015 Edison Investment Research 12 $10.00

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

07 Apr 2015 GlobalData 49 $125.00

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

17 Mar 2015 GlobalData 48 $125.00

E-THERAPEUTICS - ETS2101 PROGRESSING INTO PHASE IB TRIAL

The UK Phase Ia study of ETS2101 in solid tumours has established the maximum tolerated dose (MTD) and reported no serious dr...

15 Jan 2015 Edison Investment Research 4 $10.00

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a biot...

15 Oct 2014 GlobalData 48 $125.00

E-THERAPEUTICS - FOUR TRIALS ONGOING; GROWING DISCOVERY MOMENTUM

e-Therapeutics’ solid cash position supports increased investment in both development and discovery activities. Four clinical...

09 Oct 2014 Edison Investment Research 4 $10.00

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a biot...

08 Jul 2014 GlobalData 39 $125.00

Company Snapshot - E-Therapeutics

A director at E-Therapeutics maiden bought 100,000 shares at 29p and the significance rating of the trade was 60/100. Is tha...

04 Jul 2014 Directors Deals Ltd. 1 $12.00